» Articles » PMID: 12901596

Bacterial Ghosts As Carrier and Targeting Systems for Mucosal Antigen Delivery

Overview
Date 2003 Aug 7
PMID 12901596
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The application of new strategies to develop effective vaccines is essential in modern medicine. The bacterial ghost system is a novel vaccine delivery system endowed with intrinsic adjuvant properties. Bacterial ghosts are nonliving gram-negative bacterial cell envelopes devoid of cytoplasmic contents while maintaining their cellular morphology and native surface antigenic structures including bioadhesive properties. They are produced by PhiX174 protein E-mediated lysis of gram-negative bacteria. The intrinsic adjuvant properties of bacterial ghost preparations enhance immune responses against envelope-bound antigens, including T-cell activation and mucosal immunity. Since native and foreign antigens can be expressed in the envelope complex of ghosts before E-mediated lysis, multiple antigens of various origin can be presented to the immune system simultaneously. In addition, the extended bacterial ghost system represents a platform technology for specific targeting of DNA-encoded antigens to primary antigen-presenting cells. The potency, safety and relatively low production cost of bacterial ghosts offer a significant technical advantage, especially when used as combination vaccines.

Citing Articles

Enteral Route Nanomedicine for Cancer Therapy.

Zhang L, Du R, Wang D, Qin J, Yu C, Zhang L Int J Nanomedicine. 2024; 19:9889-9919.

PMID: 39351000 PMC: 11439897. DOI: 10.2147/IJN.S482329.


Comparison of the immune effects of the MOMP antigen displayed in different parts of bacterial ghosts.

Zhang H, Li Z, Li W, Jin Y, Li Y, Xiao Q Front Microbiol. 2024; 15:1349746.

PMID: 38389524 PMC: 10883653. DOI: 10.3389/fmicb.2024.1349746.


Immune responses and protective immunity in Pangasius pangasius (Hamilton, 1822) as induced by outer membrane proteins of Edwardsiella tarda and aluminium hydroxide adjuvant complex.

Adikesavalu H, Abraham T, Joardar S Vet Res Commun. 2022; 46(4):1097-1109.

PMID: 35927371 DOI: 10.1007/s11259-022-09978-5.


Bacteria from Infectious Particles to Cell Based Anticancer Targeted Drug Delivery Systems.

Salem-Bekhit M, Youssof A, Alanazi F, Aleanizy F, Abdulaziz A, Taha E Pharmaceutics. 2021; 13(12).

PMID: 34959266 PMC: 8706210. DOI: 10.3390/pharmaceutics13121984.


Design, development, and evaluation of the efficacy of a nucleic acid-free version of a bacterial ghost candidate vaccine against avian pathogenic E. coli (APEC) O78:K80 serotype.

Soleymani S, Tavassoli A, Tabar G, Kalidari G, Dehghani H Vet Res. 2020; 51(1):144.

PMID: 33298146 PMC: 7724879. DOI: 10.1186/s13567-020-00867-w.